Tavelmout https://www.tavelmout.jp/en/ has been founded in 2014 as a 100 % subsidiary of the Chitose group. The focus is on Spirulina-based health food products, sales in FY 2017 were close to 100 million Yen. Technology is based on the use of non-sterilised Spirulina which are odor- and tasteless. Upon sterilisation, hitherto a standard technology, Spirulina develop bitterness which prevented wide use. Tavelmout has received 1.7 billion yen investment from the Industrial Innovation Organization and Mitsubishi Co. It presently produces Spirulina in photobioreactors in Kakegawa, Shizuoka prefecture, but will build a much larger factory with improved bag-type photobioreactors in Brunei.
Source: Nikkei Biotech news release, May 23, 2018
Request a quote for deeper information from